Current issues in the economics of vaccination against dengue

@article{Tozan2016CurrentII,
  title={Current issues in the economics of vaccination against dengue},
  author={Yesim Tozan},
  journal={Expert Review of Vaccines},
  year={2016},
  volume={15},
  pages={519 - 528}
}
  • Y. Tozan
  • Published 4 January 2016
  • Medicine
  • Expert Review of Vaccines
ABSTRACT Dengue is a major public health concern in tropical and subtropical areas of the world. The prospects for dengue prevention have recently improved with the results of efficacy trials of a tetravalent dengue vaccine. Although partially effective, once licensed, its introduction can be a public health priority in heavily affected countries because of the perceived public health importance of dengue. This review explores the most immediate economic considerations of introducing a new… 
View on Taylor & Francis
www-personal.umich.edu
12 Citations
Highly Influential Citations
1
Background Citations
5

12 Citations

Citation Type

Citation Type

Dengue Dynamics and Vaccine Cost-Effectiveness Analysis in the Philippines
  • E. Shim
  • Medicine, Political Science
    The American journal of tropical medicine and hygiene
  • 2016
TLDR
An age-structured model of dengue transmission and vaccination is developed and demonstrates that even at relatively low vaccine efficacies, age-targeted vaccination may still be cost-effective provided the vaccination cost is sufficiently low.
The economic promise of developing and implementing dengue vaccines: Evidence from a systematic review.
An economic evaluation of vector control in the age of a dengue vaccine
TLDR
Sustained vector control could be highly cost-effective even with less effective technologies and in the presence of a highly targeted and low cost immunization strategy using a medium-efficacy vaccine.
Tetravalent Dengue Vaccine: A Review in the Prevention of Dengue Disease
TLDR
CYD-TDV was generally well tolerated, with no safety concerns identified after up to 4 years’ follow-up, and the availability of a dengue vaccine is considered essential if the 2012 WHO global strategy targets for reducing the burden of d Dengue disease by 2020 are to be attained.
Novel tools for the surveillance and control of dengue: findings by the DengueTools research consortium
TLDR
DengueTools was able to make significant advances in methods for understanding and controlling dengue transmission in a range of settings, which will have implications for public health agendas to counteract d Dengue, including vaccination programmes.
Systematic review of health economic evaluation studies of dengue vaccines.
Edging closer towards the goal of a dengue vaccine
TLDR
Eliciting the reasons for the imbalanced efficacy results of the CYD-TDV vaccine is now a subject of intense research.
Identification and Prioritization of the Economic Impacts of Vaccines
TLDR
This study suggests that domain A “health related benefits to vaccinated individuals” are valued as more important than the other economic impacts, including mortality, health care expenditure, and morbidity.
Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature.
Using information on the broader economic impact of vaccines in evidence-informed decision making: Connecting the dots
TLDR
The research found different preferences among stakeholders and decision-makers, who prefer to use limited information to make their decisions, and provided the right information about the possible impact of vaccination programmes through economic evaluations.
...
1
2
...

References

SHOWING 1-10 OF 127 REFERENCES
Valuing the broader benefits of dengue vaccination, with a preliminary application to Brazil.
Economic Value of Dengue Vaccine in Thailand
TLDR
A decision analytic Markov simulation model was developed to evaluate the potential health and economic value of administering a dengue vaccine to an individual (≤ 1 year of age) in Thailand from the societal perspective.
Preparing for introduction of a dengue vaccine: recommendations from the 1st Dengue v2V Asia-Pacific Meeting.
Controlling Dengue with Vaccines in Thailand
TLDR
An individual-level, stochastic simulation model for dengue transmission and control in a semi-rural area in Thailand shows that children should be prioritized to receive vaccine, but adults will also need to be vaccinated if one wants to reduce community-wide d Dengue transmission to low levels.
Economic Impact of Dengue Illness and the Cost-Effectiveness of Future Vaccination Programs in Singapore
TLDR
Dengue vaccines are expected to be cost-effective if reasonably low prices are adopted and will help to reduce the economic and disease burden of dengue in Singapore substantially.
Policymakers' views on dengue fever/dengue haemorrhagic fever and the need for dengue vaccines in four southeast Asian countries.
Will Dengue Vaccines Be Used in the Public Sector and if so, How? Findings from an 8-country Survey of Policymakers and Opinion Leaders
TLDR
Major determinants of whether and when countries will introduce dengue vaccines include whether WHO recommends the vaccines, their price, the availability of external financing for lower income countries, and whether they can be incorporated into countries' routine immunization schedules.
Health Economics of Dengue: A Systematic Literature Review and Expert Panel's Assessment
TLDR
An expert panel reviewed the existing dengue economic literature and recommended future research to fill information gaps to ensure informed decision making on the various options for controlling and preventing this disease.
Cost of dengue outbreaks: literature review and country case studies
TLDR
The evidence so far collected further confirms the methodological challenges in this field: to define technically dengue outbreaks (what do the authors measure?) and to measure accurately the costs in prospective field studies (how do they measure?).
The health and economic impact of dengue in Latin America.
TLDR
While little information exists on the economic impact of dengue in the region in terms of disease burden, the estimated loss associated with the disease is on the same order of magnitude as tuberculosis, sexually transmitted diseases, Chagas disease, leishmaniasis, or intestinal helminths; therefore, similar priority should be given in the allocation of resources for d Dengue research and control.
...
1
2
3
4
5
...